Long-term exposure to outdoor air pollution and risk factors for cardiovascular disease within a cohort of older men in Perth.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 14 06 2020
accepted: 08 03 2021
entrez: 29 3 2021
pubmed: 30 3 2021
medline: 15 10 2021
Statut: epublish

Résumé

While there is clear evidence that high levels of pollution are associated with increased all-cause mortality and cardiovascular mortality and morbidity, the biological mechanisms that would explain this association are less understood. We examined the association between long-term exposure to air pollutants and risk factors associated with cardiovascular disease. Air pollutant concentrations were estimated at place of residence for cohort members in the Western Australian Centre for Health and Ageing Health in Men Study. Blood samples and blood pressure measures were taken for a cohort of 4249 men aged 70 years and above between 2001 and 2004. We examined the association between 1-year average pollutant concentrations with blood pressure, cholesterol, triglycerides, C-reactive protein, and total homocysteine. Linear regression analyses were carried out, with adjustment for confounding, as well as an assessment of potential effect modification. The four pollutants examined were fine particulate matter, black carbon (BC), nitrogen dioxide, and nitrogen oxides. We found that a 2.25 μg/m3 higher exposure to fine particulate matter was associated with a 1.1 percent lower high-density cholesterol (95% confidence interval: -2.4 to 0.1) and 4.0 percent higher serum triglycerides (95% confidence interval: 1.5 to 6.6). Effect modification of these associations by diabetes history was apparent. We found no evidence of an association between any of the remaining risk factors or biomarkers with measures of outdoor air pollution. These findings indicate that long-term PM2.5 exposure is associated with elevated serum triglycerides and decreased HDL cholesterol. This requires further investigation to determine the reasons for this association.

Identifiants

pubmed: 33780497
doi: 10.1371/journal.pone.0248931
pii: PONE-D-20-18142
pmc: PMC8006998
doi:

Substances chimiques

Cholesterol, HDL 0
Particulate Matter 0
Triglycerides 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0248931

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Rheumatol. 2010 Aug 1;37(8):1633-8
pubmed: 20516025
Epidemiology. 2016 Mar;27(2):291-8
pubmed: 26605815
Environ Health Perspect. 2011 Oct;119(10):1384-9
pubmed: 21665568
Epidemiology. 2019 Jul;30 Suppl 1:S82-S89
pubmed: 31181010
Environ Health Perspect. 2011 Dec;119(12):1691-9
pubmed: 21810552
Prev Med. 2005 Jun;40(6):712-7
pubmed: 15850869
BMJ. 2011 Feb 15;342:d548
pubmed: 21325005
Rev Environ Health. 2012;27(2-3):133-49
pubmed: 23023922
Circulation. 2005 Dec 20;112(25):3930-6
pubmed: 16365212
Scand J Rheumatol. 2012 May;41(3):165-9
pubmed: 22401593
Clin Chem. 2003 Jan;49(1):201; author reply 201-2
pubmed: 12507987
J Clin Endocrinol Metab. 2016 Jun;101(6):2460-7
pubmed: 27218271
Arthritis Rheum. 2008 Dec 15;59(12):1690-7
pubmed: 19035419
Environ Health Perspect. 2014 Jun;122(6):624-30
pubmed: 24618231
Eur Heart J. 2017 Aug 01;38(29):2290-2296
pubmed: 28575405
Hormones (Athens). 2018 Mar;17(1):61-67
pubmed: 29858856
Int J Angiol. 1999 Jan;8(1):76-86
pubmed: 9826415
Epidemiology. 2009 Mar;20(2):245-53
pubmed: 19234416
Environ Health Perspect. 2009 Aug;117(8):1302-8
pubmed: 19672412
JAMA. 2012 May 16;307(19):2068-78
pubmed: 22665106
Chest. 2013 Jul;144(1):358-359
pubmed: 23880690
Environ Health Perspect. 2007 Jul;115(7):1072-80
pubmed: 17637925
Int J Environ Health Res. 2006 Feb;16(1):27-46
pubmed: 16507479
Eur Respir Rev. 2009 Dec;18(114):222-32
pubmed: 20956147
J Am Coll Cardiol. 2013 Jul 30;62(5):397-408
pubmed: 23727085
Int J Epidemiol. 2009 Feb;38(1):48-52
pubmed: 18316347
J Occup Environ Med. 2010 Mar;52(3):258-62
pubmed: 20190657
Am J Med. 2006 Feb;119(2):166.e17-28
pubmed: 16443421
Lancet. 2014 Aug 16;384(9943):626-635
pubmed: 25131982
Lancet Neurol. 2016 Aug;15(9):913-924
pubmed: 27291521
Diabetologia. 2003 Jun;46(6):733-49
pubmed: 12774165
BMJ Glob Health. 2019 Jan 24;4(1):e001017
pubmed: 30740247
Environ Int. 2015 Aug;81:1-7
pubmed: 25898227
J Expo Sci Environ Epidemiol. 2006 May;16(3):225-37
pubmed: 16118657
Int J Hyg Environ Health. 2018 Apr;221(3):510-518
pubmed: 29428699
Ann Clin Biochem. 2002 Mar;39(Pt 2):85-8
pubmed: 11928769
Metabolism. 2006 Jul;55(7):980-8
pubmed: 16784973
Environ Health Perspect. 2009 Jun;117(6):995-1001
pubmed: 19590696
J Lipid Res. 2004 Jul;45(7):1169-96
pubmed: 15102878
Occup Environ Med. 2009 Nov;66(11):747-53
pubmed: 19687019
Aust N Z J Public Health. 2005 Jun;29(3):205-12
pubmed: 15991767
Diabetes Metab. 2012 Dec;38(6):523-30
pubmed: 23062595
BMJ. 2000 Jul 22;321(7255):199-204
pubmed: 10903648
Circulation. 2010 Jun 1;121(21):2331-78
pubmed: 20458016
Circulation. 2004 Jun 1;109(21):2655-71
pubmed: 15173049
Lancet. 2018 Nov 10;392(10159):1923-1994
pubmed: 30496105
Thorax. 1999 Nov;54(11):1027-32
pubmed: 10525563
Arterioscler Thromb Vasc Biol. 2017 May;37(5):976-982
pubmed: 28408373
Environ Health Perspect. 2004 Mar;112(3):339-45
pubmed: 14998750
Circulation. 2004 Jan 6;109(1):71-7
pubmed: 14676145
Chest. 2013 Feb 1;143(2):452-460
pubmed: 22910717
Am J Cardiol. 2008 Dec 15;102(12):1631-43
pubmed: 19064017
Occup Environ Med. 2011 Jan;68(1):64-8
pubmed: 20833756

Auteurs

Stephen Vander Hoorn (S)

School of Population and Global Health, The University of Western Australia, Perth, Australia.
Centre for Air Pollution, Energy and Health Research, Glebe, New South Wales, Australia.

Kevin Murray (K)

School of Population and Global Health, The University of Western Australia, Perth, Australia.

Lee Nedkoff (L)

School of Population and Global Health, The University of Western Australia, Perth, Australia.

Graeme J Hankey (GJ)

Medical School, The University of Western Australia, Crawley, Australia.

Leon Flicker (L)

Medical School, The University of Western Australia, Crawley, Australia.
WA Centre for Health & Ageing, The University of Western Australia, Crawley, Australia.

Bu B Yeap (BB)

Medical School, The University of Western Australia, Crawley, Australia.
Department of Endocrinology and Diabetes, Fiona Stanley Hospital, Perth, Western Australia, Australia.

Osvaldo P Almeida (OP)

Medical School, The University of Western Australia, Crawley, Australia.
WA Centre for Health & Ageing, The University of Western Australia, Crawley, Australia.

Paul Norman (P)

Medical School, The University of Western Australia, Crawley, Australia.

Bert Brunekreef (B)

Institute for Risk Assessment Sciences, Utrecht University, Utrecht, Netherlands.

Mark Nieuwenhuijsen (M)

Institute for Global Health, Barcelona, Spain.

Jane Heyworth (J)

School of Population and Global Health, The University of Western Australia, Perth, Australia.
Centre for Air Pollution, Energy and Health Research, Glebe, New South Wales, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH